Compare · DELL vs OMCL
DELL vs OMCL
Side-by-side comparison of Dell Technologies Inc. (DELL) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DELL and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- DELL is the larger of the two at $300.99B, about 183.5x OMCL ($1.64B).
- Over the past year, DELL is up 201.8% and OMCL is up 18.4% - DELL leads by 183.4 points.
- DELL has been more active in the news (39 items in the past 4 weeks vs 1 for OMCL).
- DELL has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- Dell Technologies Inc.
- Omnicell Inc.
- Price
- $451.16-4.80%
- $35.40-1.48%
- Market cap
- $300.99B
- $1.64B
- 1M return
- -23.28%
- +8.56%
- 1Y return
- +201.78%
- +18.36%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- 2001
- News (4w)
- 39
- 1
- Recent ratings
- 25
- 24
Dell Technologies Inc.
Dell Technologies Inc. designs, develops, manufactures, markets, sells, and supports Information technology solutions, products, and services worldwide. It operates through three segments: Infrastructure Solutions Group (ISG), Client Solutions Group (CSG), and VMware. The ISG segment provides traditional and next-generation storage solutions; and rack, blade, tower, and hyperscale servers. This segment also offers networking products and services that help its business customers to transform and modernize their infrastructure, mobilize and enrich end-user experiences, and accelerate business applications and processes; attached software and peripherals; and support and deployment, configuration, and extended warranty services. The CSG segment provides desktops, workstations, and notebooks; displays and projectors; attached and third-party software and peripherals, as well as support and deployment, configuration, and extended warranty services. The VMware segment supports and addresses various IT priorities of customers, including accelerating their cloud journey, migrating and modernizing their applications, empowering digital workspaces, transforming networking, and embracing intrinsic security. It enables its customers to digitally transform their operations as they ready their applications, infrastructure, and employees for constantly evolving business needs. This segment also offers cloud-native platform that makes software development and IT operations a strategic advantage for customers. The company also provides information security; cloud software and infrastructure-as-a-service solutions that enable customers to migrate, run, and manage mission-critical applications in cloud-based IT environments; cloud-based integration services; and financial services. The company was formerly known as Denali Holding Inc. and changed its name to Dell Technologies Inc. in August 2016. Dell Technologies Inc. was founded in 1984 and is headquartered in Round Rock, Texas.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest DELL
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- Dell downgraded by Barclays with a new price target
- SEC Form 144 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
- SEC Form 4 filed by Dell Technologies Inc.
Latest OMCL
- Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
- TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
- Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
- EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 4,025 shares, decreasing direct ownership by 4% to 108,985 units (SEC Form 4)
- VP, Chief Accounting Officer Nutt Brian H. covered exercise/tax liability with 937 shares, decreasing direct ownership by 4% to 22,266 units (SEC Form 4)
- President & COO Njoku Nnamdi covered exercise/tax liability with 3,670 shares and sold $113,609 worth of shares (3,083 units at $36.85) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,224 units (SEC Form 4)
- CHAIRMAN, CEO Lipps Randall A covered exercise/tax liability with 12,350 shares, decreasing direct ownership by 2% to 511,096 units (SEC Form 4)
- SEC Form 10-Q filed by Omnicell Inc.
- EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits